A rapid diagnostic test for detection of influenza A and B viruses. FDA 510(k) cleared for clinical and home-based testing.
Manufactured by
United States
Wondfo USA is a branch of Wondfo Biotech Co., Ltd. located in the United States. Wondfo USA distributes rapid drug testing kits as well as other POCT products, which are manufactured by its parent company. Headquartered in Guangzhou, China, Wondfo is a globally recognized fast-growing POCT manufacturer specialized in R&D, manufacture, and sales of rapid diagnostic tests and related medical devices for in vitro diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Boston Easy Biotech Inc.
United States · 2 relevant products
Famwell
United States · 3 relevant products
Atlas Link, Inc.
United States · 1 relevant product
GenSure Biotech Inc.
China · 2 relevant products
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD
China · 1 relevant product
Operon S.A.
Spain · 2 relevant products
ProGnosis Biotech S.A.
Greece · 3 relevant products
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 2 relevant products
Anbio Biotechnology Limited
Germany · 1 relevant product
64 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
Boston Easy Biotech Inc. · United States
FDA-cleared rapid diagnostic test for simultaneous detection of Influenza A and B antigens. Provides fast, reliable results in clinical and point-of-care settings. Designed for ease of use and quick turnaround in respiratory infection screening.
Famwell · United States
A rapid antigen diagnostic test for simultaneous detection of both influenza A and influenza B viruses.
Boston Easy Biotech Inc. · United States
FDA-cleared rapid antigen test for simultaneous detection of Influenza A and B. Designed for clinical and point-of-care settings, this test delivers fast, reliable results to support timely diagnosis and patient management. Suitable for respiratory screening in healthcare facilities and retail pharmacy channels.
Famwell · United States
FDA 510(k) cleared and CLIA waived cassette-format test for rapid detection of influenza A and B antigens from nasopharyngeal swabs. Provides results within 10 minutes with 85.7% positive predictive accuracy and high negative predictive accuracy. Packaged in boxes of 25 tests with 18-month shelf life.
Atlas Link, Inc. · United States
A rapid diagnostic test for the detection of influenza A and B viruses. The test is included in Atlas Link's respiratory and COVID-19 diagnostic portfolio with FDA registration, CE marking, and ISO 13485 certification.
GenSure Biotech Inc. · China
Rapid antigen detection test kit for simultaneous identification of Influenza A and B viruses from respiratory specimens. Delivers results within minutes using immunochromatographic technology, enabling point-of-care diagnosis in clinical and home settings. NMPA-approved for accurate respiratory pathogen screening.
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD · China
Rapid diagnostic test for simultaneous detection of influenza A and B viruses using nasopharyngeal or throat swab specimens. Provides reliable results for clinical decision-making in respiratory illness assessment.
Operon S.A. · Spain
A rapid diagnostic test for the simultaneous detection of Influenza A and B viruses in human samples. Used for in vitro diagnosis of respiratory infections.
ProGnosis Biotech S.A. · Greece
Rapid lateral flow test kit for simultaneous Influenza A and B detection. Validated diagnostic tool certified to ISO 13485:2016 medical device standards.
guangzhou biotron technolongy co.,ltd · China
Rapid diagnostic test for detection and differentiation of influenza A and B viruses from respiratory samples for acute respiratory infection diagnosis.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A rapid diagnostic test designed for the detection and differentiation of Influenza A and Influenza B antigens in clinical specimens. This test provides quick results to support timely clinical decision-making and patient management.
Anbio Biotechnology Limited · Germany
Rapid immunochromatographic assay for simultaneous detection of influenza A and B viral antigens. Provides point-of-care results for acute respiratory illness diagnosis.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products